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Abstract
Abnormal venous reflux caused by venous incompetence has been the dominant concept in chronic venous
insufficiency; however, the pivotal role of iliac venous obstructive lesions is now well recognised. Greater
consideration should be given to investigating obstructive lesions when treating patients with venous ulcers,
recurrent venous thrombosis and unresolved venous disease such as pelvic congestion syndrome.
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Chronic venous insufficiency (CVI) is a condition affecting the lower limbs that is characterised by persistent ambulatory venous hypertension causing problems such as pain, oedema, skin changes and ulceration. 
Although the term CVI is often used to imply the more advanced 
manifestations of chronic venous disease, it is considered by 
vascular specialists to include the full spectrum of this disease.1 
This ranges from varicose veins, which involve incompetent 
valves and increased venous pressure, to hyperpigmentation, 
venous eczema, lipodermato sclerosis, atrophie blanche and 
healed or active ulcers.
CVI has a high prevalence and considerable socioeconomic 
impact, so an understanding of its clinical manifestations, diag-
nostic modalities and new therapeutic options is warranted. This 
article reviews clinical aspects of CVI, focusing on the diagnostic 
and therapeutic options for venous obstruction, as most of the 
available literature focuses on venous incompetence.
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Abnormal venous reflux caused by venous 
incompetence has been the dominant concept in 
chronic venous insufficiency; however, the pivotal 
role of iliac venous obstructive lesions is now well 
recognised. Greater consideration should be given to 
investigating obstructive lesions when treating 
patients with venous ulcers, recurrent venous 
thrombosis and unresolved venous disease such 
as pelvic congestion syndrome.
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  KEY POINTS
• Venous disease contributes considerably to the burden of 
disease for patients and healthcare services but is under-
researched and undertreated.
• Venous obstruction has been a largely neglected cause of 
chronic venous disease and remains underdiagnosed.
• Patients presenting with severe symptoms of chronic 
venous insufficiency or a history of thrombosis should be 
evaluated with a thorough history, physical examination 
and detailed lower-extremity venous duplex scans, and 
referred to a vascular specialist to rule out iliac venous 
obstructive lesions.
• Percutaneous balloon angioplasty and stenting appear to 
be a safe and effective treatment for venous obstruction, 
with significant clinical resolution of symptoms, 
prevention of recurrence of thrombosis and ulceration and 
acceptable long-term patency.
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Relevance
CVI is important because of the number 
of people affected and the socioeconomic 
impact of its more severe manifestations. 
It is a common problem that affects people 
psychologically, as patients with CVI often 
develop depression and anxiety, as well as 
clinically.2
Although there are no data on the 
 prevalence of CVI in the Australian pop-
ulation, the prevalence of varicose veins in 
countries with a similar ethnic composition 
ranges from 6.8 to 39.7% in men and 24.6 
to 39.0% in women.3 Data from Medicare 
Australia suggest that the largest group of 
patients requiring treatment for varicose 
veins is women between the ages of 35 and 
64 years.3 
Because of the dynamic and recurrent 
nature of venous disease, most vein condi-
tions are long term and often require mul-
tiple treatments. A study evaluating more 
than 91,000 patients in various  geographic 
regions found that clinically significant 
chronic venous disease was present in about 
60% of the population worldwide.4 Approx-
imately 20% of all patients with CVI will 
develop venous ulcers, and active or healed 
ulcers are present in about 1% of the adult 
population.5-9 
Delayed healing and a high rate of recur-
rent ulceration mean that the overall prog-
nosis of venous ulcers is poor. Recurrence 
rates have been shown to be 50 to 76%, and 
an Australian study showed the point 
 prevalence of leg ulcers to be 0.1%.1,5,10 
The socioeconomic impact of venous 
ulceration is multifactorial. Disability 
related to venous ulcers leads to the loss of 
productive work hours, with an estimated 
two million workdays lost per year in the 
USA.1 It can also lead to early retirement, 
which has been found to occur in more 
than 12% of workers with venous ulcers.1,6
On top of this, the financial burden of 
venous ulcer disease on the healthcare sys-
tem is estimated to be 1 to 2% of the total 
healthcare budget. This means that the 
annual cost of venous ulcer care in Australia 
is about A$3 billion.5,8 In Australia, the care 
of patients with venous ulcers has now partly 
shifted from the acute care sector into the 
community, where wound care services and 
products are not fully subsidised by the 
government. A pilot study in 2010 indicated 
that the average expenses incurred by people 
with CVI in the process of managing their 
venous leg ulcers was A$114 per month. 
This result was concerning, considering the 
average weekly income from the aged pen-
sion was A$206, indicating that about 13% 
of total weekly income was being spent on 
treatment and management of leg ulcers.11
Pathophysiology
The proper functioning of the venous 
 system depends on patency of the vessels, 
 one-way valves and muscle pumps. In the 
erect position, blood that enters the l ower- 
extremity venous system must travel against 
gravity to return to the central circulation. 
Contraction of the muscle pumps, primarily 
in the calf, forces blood up the deep venous 
system. The valves prevent blood from being 
forced more distally within the deep venous 
system or through perforator veins into the 
superficial system. 
Immediately after ambulation, the 
 pressure within the veins of the lower 
extremities is normally low because the 
venous system has been emptied by the 
muscle pump action. With prolonged 
standing, the veins become distended as 
they fill via antegrade flow, allowing the 
valves to open and pressure to increase. 
Venous disease develops when venous 
pressure is increased and the return of blood 
is impaired.12 This may result from valvular 
incompetence, venous obstruction or a com-
bination of these mechanisms. 
Lower-limb venous pressure changes 
depend on ambulation, rest and standing 
position. In a person with normal venous 
function, the resting standing venous pres-
sure is about 80 to 90 mmHg. The pressure 
decreases by more than 50% with calf exer-
cise, dropping to 20 to 30 mmHg, and the 
return to resting pressure is gradual, with 
refill taking more than 20 seconds. If abnor-
mal venous reflux is present (in patients 
with valve incompetence) then the resting 
standing pressure is usually higher than 
normal and the decrease in pressure with 
calf exercise is blunted (less than 50% 
decrease). There is also a faster return in 
CHRONIC VENOUS INSUffICIENCy continued 
Figure 1. Depiction of ambulatory foot venous pressure during exercise (toe stands) and 
subsequent rest in the standing position, illustrating normal venous function (blue line), abnormal 
venous reflux (purple line) and abnormal venous pressure with venous obstruction (red line).
Reproduced with permission from Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation 2014; 130: 333-346.
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venous pressure to the resting level because 
of the short refill time (less than 20 seconds). 
In patients with venous obstruction, the 
resting standing venous pressure is again 
higher than normal, but there is minimal 
to no drop in pressure with calf exercise 
(Figure 1).1 This means that patients with 
venous obstruction do not benefit from 
exercise as patients with venous reflux do.
Venous obstruction and pelvic vein 
insufficiency
Venous outflow obstruction has been largely 
neglected as a cause of chronic venous 
 disease, partly because valve incompetence 
and venous reflux were the focus of attention 
and partly because treatment options were 
limited to invasive surgical techniques, such 
as bypass grafting, with limited patency 
rates. Over the past two decades, however, 
minimally invasive treatment options have 
gained popularity, mainly through improve-
ments in endovascular technology. 
Venous obstruction may result from an 
intrinsic venous process, such as chronic 
deep vein thrombosis, or from extrinsic 
compression. May–Thurner syndrome, 
also known as Cockett’s syndrome or iliac 
vein compression syndrome, is most often 
described as compression of the left com-
mon iliac vein between the right common 
iliac artery and the lumbar vertebrae, which 
causes the development of fibrosis (much 
like scar tissue) inside the vein.13 This leads 
to progressive stenosis and the development 
of venous disease symptoms. The pelvic 
veins can also be compressed at other 
points by other segments of artery or by 
overlying structures such as an enlarged 
uterus or a tumour. 
Venous outflow obstruction plays a 
significant role in the pathogenesis of CVI.14 
Venous obstruction, as well as deep vein 
valve dysfunction, is associated with a high 
rate of venous ulceration (Figures 2a and 
b) and more rapid progression of disease 
than in superficial venous valve incompe-
tence. A study of intravascular ultrasound 
examinations found that iliac vein obstruc-
tive lesions were present in 938 limbs of 879 
patients with severe symptoms of CVI; 53% 
of the limbs had nonthrombotic iliac vein 
lesions, 40% were post-thrombotic and 7% 
were a combination.15
Despite a high incidence in the general 
population, venous obstruction is often 
asymptomatic and remains underdiag-
nosed. It has been suggested that iliac vein 
lesions act as permissive lesions, and it is 
the addition of factors such as trauma, cel-
lulitis, distal thrombosis, lymphatic exhaus-
tion or reflux that renders the extremity 
symptomatic.15 In the elderly, atheroscle-
rosis of the overlying artery, venosclerosis, 
decreasing mobility and leg dependency 
or other comorbid conditions predisposing 
to pedal oedema may be contributory fac-
tors in symptom expression. In some cases, 
no secondary aggravating factors are appar-
ent, and symptom expression may simply 
be related to further progression of the 
 stenotic lesion.16
Clinical manifestations 
CVI represents a spectrum of conditions 
ranging from simple telangiectasia or retic-
ular veins to more advanced stages, such 
as skin fibrosis and venous ulceration. The 
same clinical manifestations may result 
from different pathogenic mechanisms, 
including incompetent valves, venous 
obstruction, muscle pump dysfunction or 
a combination of these. Some patients 
whose iliac veins are narrowed by 50% or 
more will develop one or more symptoms. 
The symptoms are caused by high pressure 
in the veins resulting from the obstruction 
and the enlargement of other veins to carry 
blood flow around the obstruction and 
back to the heart.
Iliac vein thrombosis secondary to an 
obstructive lesion is well recognised and 
thought to occur in 18 to 69% of patients 
with lower-extremity deep vein thrombo-
sis.17 Patients who have compression or 
stenosis of an iliac vein may be more prone 
to developing thrombosis if they also have 
other risk factors for clotting, such as use 
of oral contraceptives or oestrogen therapy, 
pregnancy, extended sedentary periods or 
inherited disorders that increase the risk 
of abnormal clotting (e.g. factor V Leiden 
mutation, factor II prothrombin mutation, 
protein S or protein C deficiency or 
antithrombin III deficiency). 
Varicose veins in the abdomen or groin 
that appear distended even in the supine 
position or that are present in nonsaphen-
ous territories are highly indicative of a 
pelvic source (Figure 3). Orthostatic limb 
pain or pain after exercise (claudication 
Figures 2a and b. Ulcers in patients with iliac stenosis. a (left). Longstanding bilateral leg 
ulcers in a patient with bilateral iliac stenosis. b (right). Nonhealing ulcer in a 47-year-old 
patient with severe iliac stenosis.
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type pain) in the younger population (aged 
under 30 years) should raise suspicion of 
pelvic vein obstruction.18 Exercise-induced 
pain usually occurs in the thigh and occa-
sionally the calf muscles. Such venous 
claudication, described by patients as a 
bursting sensation or throbbing/pressure 
type of pain, is relieved by rest and elevation 
of the legs. A syndrome of spinal claudica-
tion caused by spinal compression by 
venous collaterals has also been described.19
Severe leg swelling, particularly when 
affecting the thigh, should also suggest a 
pelvic source. Pelvic pain, lower back pain 
or urinary bladder discomfort are common 
findings in patients with iliac vein obstruc-
tive lesions and pelvic vein insufficiency. 
Patients often present with unilateral or 
bilateral lower abdominal or pelvic pain, 
which is generally chronic and dull, 
although acute and severe pain may occur. 
The pain, described as heaviness and full-
ness in the lower pelvis, thighs and vulvar 
region or scrotum, is exacerbated in women 
during menses and may be associated with 
postcoital ache, dyspareunia, perineal pain, 
urinary urgency and atypical varicosities, 
such as pudendal, vulvar and perilabial 
veins and varicoceles.20 Incompetent veins 
can also collateralise along the posterolat-
eral thigh and gluteal regions.21 
Patients with venous obstruction can 
experience bleeding from high-pressure 
varicosities, and the venous congestion 
occasionally results in hyperhidrosis and 
significant fluid loss through the skin. Skin 
changes can include pigmentation caused 
by haemosiderin deposition and eczema-
tous dermatitis.16 Lipodermatosclerosis is a 
fibrotic process that may occur in the  dermis 
and subcutaneous fat. There is an increased 
risk of cellulitis, leg ulceration and delayed 
wound healing in patients with venous 
obstruction. In addition, protracted CVI 
may contribute to the development of 
lymphoedema,  representing a combined 
process.
Depression and anxiety are common 
comorbidities in patients with venous 
obstruction, often owing to a prolonged 
time to diagnosis, and these comorbidities 
may also have a physiological cause. In 
response to the shearing and stretching of 
the congested pelvic veins, endothelial and 
smooth- muscle cells release vasodilator 
substances, which play a key role in regu-
lating emotions and stress.22
As the symptoms of venous obstruction 
progress slowly over many years, patients 
often adapt their lifestyles accordingly and 
do not seek medical attention until symp-
toms become severe. Many patients have 
reported unknowingly decreasing their 
level of physical activity as the symptoms 
worsened, attributing them to being part 
of the normal ageing process.
Diagnosis of venous obstruction
Investigation of patients with suspected 
venous insufficiency begins with a thorough 
history and physical examination, followed 
by a detailed lower-extremity venous 
duplex scan to evaluate obstruction and 
valvular incompetence of both deep and 
superficial venous systems. 
The appropriate diagnosis of venous 
obstruction requires a high degree of 
 suspicion and a low threshold for extend-
ing investigations beyond duplex ultra-
sound evaluation of the lower extremity. 
Pelvic imaging (transabdominal duplex, 
computed tomography or magnetic 
 resonance imaging) should be obtained 
to exclude malignancy, benign tumours, 
retroperitoneal fibrosis and other 
aetiologies.
The diagnosis of venous outflow 
obstruction largely depends on anatomical 
rather than haemodynamic criteria. 
Transfemoral venography is the standard 
method of imaging the venous outflow 
tract and may disclose the site of obstruc-
tion (Figure 4). However, intravascular 
ultrasound is superior to  venography in 
estimating the morphological degree and 
extent of iliac vein  stenosis and visualising 
details of intraluminal lesions.23
Patients should be referred to a vascular 
specialist for further investigation if they: 
• have a previous history of deep or 
superficial vein thrombosis (especially 
if it is recurrent or unprovoked)
• have venous ulceration
• have a lower-limb venous duplex 
scan that has indicated a pelvic 
source for their varicosities
CHRONIC VENOUS INSUffICIENCy continued 
Figure 3. Abdominal and groin veins in a 
patient with severe iliac vein compression. 
Figure 4. Venogram in a 20-year-old patient 
with May–Thurner syndrome, showing pelvic 
and paravertebral collaterals causing 
incapacitating pelvic congestion syndrome.
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• are young and complaining of leg 
claudication
• have severe oedema (especially if 
affecting the thigh)
• have pelvic congestion symptoms
• have vulvar varicosities or varicoceles.
It is important to note that patients may 
present with one or a combination of these 
symptoms.
Treatment of venous obstruction 
Conservative management methods tradi-
tionally used for CVI, such as gradual com-
pression stockings and exercise, are usually 
not beneficial in treating venous obstruction 
and often cause the patient increased dis-
comfort and pain. Percutaneous venous 
balloon angioplasty and stenting is emerg-
ing as a safe and effective alternative to 
traditional open surgery (Figures 5a to c).
The mortality rate after endovenous 
stenting is nil and the morbidity rate is less 
than 1%.24 In a review of multiple reports 
involving about 1500 patients, patency was 
found to be 90 to 100% for nonthrombotic 
disease and 74 to 89% for post-thrombotic 
disease at three to five years.25 The clinical 
efficacy of iliofemoral venous stenting is 
supported by reports of significant relief of 
pain and swelling and high rates of ulcer 
healing. Objectively documented swelling 
is completely relieved in about a third of 
limbs and significantly reduced in others, 
and about half of patients have complete 
relief of pain after stenting.24 Despite the 
presence of untreated reflux in many limbs, 
about half of ulcerated legs will heal, and 
remain healed for up to two years, after 
iliac vein stent placement.17,24,25 
A recent study of 220 women treated 
for pelvic congestion syndrome found that 
82% of those with pelvic venous reflux had 
an iliac vein obstruction. The authors 
 concluded that in patients with iliac vein 
obstructive lesions and ovarian incompe-
tence, the iliac vein lesion should be treated 
first, and ovarian reflux should only be 
treated if symptoms persist.26
Conclusion
The pivotal role of iliac venous obstructive 
lesions in the development of CVI and 
thrombosis is now well recognised. 
Patients presenting with severe symptoms 
of CVI or a history of thrombosis should 
be  thoroughly evaluated. Percutaneous 
 balloon angioplasty and stenting appear 
to be a safe and effective treatment for 
venous obstruction, with significant clin-
ical resolution of symptoms, prevention 
of recurrence of thrombosis and ulceration 
and acceptable long-term patency.   MT
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Figures 5a to c. Venograms before and after stenting in a patient with chronic venous insufficiency. a (left). Severe compression of the proximal left 
common iliac vein, with numerous pelvic collaterals diverting flow to the right iliac system. b (centre). Balloon wasting at the site of severe stenosis. 
c (right). Resolution of stenosis after stenting, with antegrade flow through the left common iliac vein and disappearance of collateral flow.
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